A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
Laperche S, Maniez M, Barlet V, El Ghouzzi MH, Le Vacon F, Levayer T, Lunel F, Morel P, Mouillot L, Piquet Y, Pillonel J; Transfusion-Transmissible Agents Working Group, French National Society of Blood Transfusion.
Laperche S, et al. Among authors: morel p.
Transfusion. 2008 Nov;48(11):2308-14. doi: 10.1111/j.1537-2995.2008.01873.x. Epub 2008 Jul 23.
Transfusion. 2008.
PMID: 18673347